Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clozapine plus lamotrigine in treatment-resistant schizophrenia.

× No keyword cloud information.

13 in total

Review 1. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors: John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal: Psychopharmacology (Berl) Date: 2003-09-02 Impact factor: 4.530

Review 2. Augmentation strategies in clozapine-resistant schizophrenia.

Authors: Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal: CNS Drugs Date: 2005 Impact factor: 5.749

Review 3. The potential role of lamotrigine in schizophrenia.

Authors: Charles H Large; Elizabeth L Webster; Donald C Goff
Journal: Psychopharmacology (Berl) Date: 2005-10-12 Impact factor: 4.530

Review 4. Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors: Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal: J Child Psychol Psychiatry Date: 2010-02-26 Impact factor: 8.982

5. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

Authors: N F Idris; P Repeto; J C Neill; C H Large
Journal: Psychopharmacology (Berl) Date: 2005-01-12 Impact factor: 4.530

6. Clozapine-related EEG changes and seizures: dose and plasma-level relationships.

Authors: Seema Varma; Delia Bishara; Frank M C Besag; David Taylor
Journal: Ther Adv Psychopharmacol Date: 2011-04

7. Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study.

Authors: Sanjiv Kumra; Harvey Kranzler; Ginny Gerbino-Rosen; Hana M Kester; Courtney DeThomas; Kathyrn Cullen; James Regan; John M Kane
Journal: J Child Adolesc Psychopharmacol Date: 2008-08 Impact factor: 2.576

Review 8. Glutamate and dopamine in schizophrenia: an update for the 21st century.

Authors: Oliver Howes; Rob McCutcheon; James Stone
Journal: J Psychopharmacol Date: 2015-01-13 Impact factor: 4.153

9. Treatment of the special patient with schizophrenia.

Authors: R R Conley; D L Kelly
Journal: Dialogues Clin Neurosci Date: 2001-06 Impact factor: 5.986

10. Current perspectives in the treatment of resistant schizophrenia.

Authors: R K Solanki; Paramjeet Singh; Deepti Munshi
Journal: Indian J Psychiatry Date: 2009 Oct-Dec Impact factor: 1.759